Bridging Gaps in Postpartum Care: Exploring STAMPP-HTN and Disparities in Postpartum Health

July 18, 2024 | 10:00 - 11:00AM PT

Dr. Rana will be discussing the risk of postpartum hypertension and the disparity in care of women in the postpartum period. She will be discussing the creation and implementation of the STAMPP- HTN program.

The Systematic Treatment and Management of Postpartum Hypertension (STAMPP-HTN) integrates evidence-based interventions, including remote blood pressure monitoring and telehealth visits, to enhance and standardize the clinical care of women with postpartum hypertension. This program has improved rates of postpartum follow-up visits and eliminated racial disparities in their patient population. It is currently standard of care at the University of Chicago.

Presentation topics include:

  • Understand the importance of follow-up for postpartum women
  • Understand disparities as it pertains for postpartum care
  • Learn about the Systematic Treatment and Management of Postpartum Hypertension (STAMPP-HTN) program

Register via GoToWebinar.

Thursday, July 18, 2024: 10:00 a.m.- 11:00 a.m. (PT)

Sarosh Rana, MD, MPH, FACOG
Professor of Obstetrics and Gynecology 
Section Chief, Maternal-Fetal Medicine
Chief Obstetrical Transformation Officer 
The University of Chicago Medicine

Dr. Rana is a Professor of Obstetrics and Gynecology and section Chief of Maternal Fetal Medicine at the University of Chicago. She is also Chief Obstetrical Transformation Officer for the University of Chicago health systems. In this role, she works closely with the South Side Healthy Community Organization (SSHCO). She engages with safety net hospitals and community health centers on the South Side of Chicago and in the Southland to develop systems of care and processes to improve access to OB care and support services for patients within these areas. Dr. Rana is an internationally recognized expert in the management of hypertensive disorders of pregnancy. She takes care of pregnant and postpartum patients with high-risk conditions such as preeclampsia, hypertension, kidney transplant, heart failure, and obesity. Dr. Rana performs translational research. For the past 20 years, her lab has worked on angiogenic biomarkers and treatment of preeclampsia. She is particularly interested in elucidating the role of angiogenic biomarkers in predicting adverse maternal and fetal outcomes. Dr. Rana is also interested in reducing health disparities through quality improvement initiatives. Dr. Rana conducts national and international research. She trains medical students, residents, and fellows and is also the Program Director of an OB/GYN translational research fellowship.

HQI is an approved continuing education (CE) provider by the California Board of Registered Nursing and will provide CHPSO members an opportunity to earn CEs. Provider Number CEP16793 for 1.0 contact hour.

Please contact CHPSO at info@chpso.org if you have any questions.